Matthew R. Patterson
InvestorFounderVenture Partner at SR One Capital Management · Chairman of the Board of Directors at Rezo Therapeutics · Board director at Addition Therapeutics · Director at Remix Therapeutics
San Francisco Bay Area
FoundedAudentes Therapeutics
Find your path to Matthew
411 people in our graph share verified history with Matthew — schools, employers, funds. One of them is your warm intro.
Scott BillerunlockedMatthew: together at Remix Therapeutics (2021–2026)
Matthew: together at Vor Biopharma
×2Matthew: together at SR One Capital Management
×4Matthew: together at Genzyme
About
Matthew R. Patterson is a Venture Partner at SR One Capital Management with over 30 years in the research, development, and commercialization of therapeutics. He co-founded Audentes Therapeutics in 2012 and served as its CEO until its 2020 acquisition by Astellas Pharma, and previously worked at Genzyme, BioMarin Pharmaceutical, Amicus Therapeutics, and Iris Medicine, as well as serving as an Entrepreneur-In-Residence at OrbiMed. He holds a Bachelor's degree in Biochemistry from Bowdoin College.
Contact· self-published, not guessed
Likely email· guessed from name + firm domain, not firm-published
- m•••@srone.comreveal100% confident
Invests in
Biotech
Chairman of the Board of Directors at Rezo Therapeutics
Intro paths
→
In turn, Matthew can intro founders to Rezo Therapeutics's investors below.
Rezo Therapeutics's investors · 6
Andreessen HorowitzMenlo Park · $500K – $50M checks · since 2022ARCH Venture PartnersChicago · $50K – $250M checks · since 2025HAWKTAILSan FranciscoNorwest Venture PartnersMenlo Park · $10M – $30M checks · since 2022SR One Capital ManagementRedwood City · since 2022Valkyrie Ventures Management, LlcPark City
Co-founders at Rezo Therapeutics
NK
Nevan KroganCo-Founder
SB
Sourav BandyopadhyayCo-Founder
NB
Norbert BischofbergerCo-Founder
NJ
Natalia JuraCo-Founder
GS
George ScangosCo-Founder
KS
Kevan ShokatCo-Founder
Board director at Addition Therapeutics
Intro paths
→
In turn, Matthew can intro founders to Addition Therapeutics's investors below.
Addition Therapeutics's investors · 4
Co-founders at Addition Therapeutics
KC
Kathleen CollinsDirector
Director at Remix Therapeutics
Intro paths
→
In turn, Matthew can intro founders to Remix Therapeutics's investors below.
Remix Therapeutics's investors · 5
Co-founders at Remix Therapeutics
PS
Peter Smith, PhDCo-Founder, President and Chief Executive Officer
PS
Peter SmithCo-Founder, President and Chief Executive Officer
Experience
- SR One Capital ManagementVenture Partnercurrent2024 — presentSan Francisco Bay Area
- Addition TherapeuticsChairman of the Boardcurrent2025 — present
- Addition TherapeuticsExecutive Chairman2024 — 2025San Francisco Bay Area
- Rezo TherapeuticsChairman of the Boardcurrent2025 — present
- Rezo TherapeuticsMember Board of Directorscurrent2025 — present
- Remix TherapeuticsChairman of the Boardcurrent2024 — presentCambridge, Massachusetts, United States
- Remix TherapeuticsExecutive Chairman2021 — 2024
- Vor BiopharmaMember, Board of Directors2020 — 2025Cambridge, Massachusetts, United States
- Vor BiopharmaChairman of the Board2021 — 2025Cambridge, Massachusetts, United States
- Iris MedicineChairman and Chief Executive Officer2022 — 2024San Francisco Bay Area
- Iris MedicineExecutive Chairman2022San Francisco Bay Area
- Homology Medicines, Inc.Member, Board of Directors2018 — 2024
- Alliance for Regenerative MedicineMember, Board of Directors2015 — 2021Washington DC-Baltimore Area
- Alliance for Regenerative MedicineChairman Of The Board2019 — 2020
- Alliance for Regenerative MedicineVice Chairman Of The Board2017 — 2018
- Audentes TherapeuticsStrategic Advisor2020 — 2021San Francisco Bay Area
- Audentes TherapeuticsChairman and Chief Executive Officer2018 — 2020San Francisco Bay Area
- Audentes TherapeuticsChief Executive Officer2018San Francisco Bay Area
- Audentes TherapeuticsPresident and CEO2013 — 2018San Francisco, CA
- Modis Therapeutics, Inc.Member Board Of Directors2018 — 2019San Francisco Bay Area
- Gilda's Club New York CityMember, Board of Directors2010 — 2019
- OrbiMedEntrepreneur-In-Residence2011 — 2012Greater New York City Area
- Amicus TherapeuticsPresident and Acting Chief Executive Officer2011
- Amicus TherapeuticsPresident and Chief Operating Officer2011
- Amicus TherapeuticsChief Operating Officer2006 — 2011
- Amicus TherapeuticsChief Business Officer2004 — 2006
- BioMarinVice President, Commercial Planning and Government Affairs2003 — 2004
- BioMarinManager/Director/Vice President, Regulatory and Government Affairs1998 — 2003
- GenzymeAssociate/Senior Associate/Principal Associate, Regulatory Affairs1995 — 1998
- GenzymeSenior Manufacturing Technician1993 — 1995
Investments
Board seats
Addition TherapeuticsAddition TherapeuticsRemix Therapeutics, Inc.Vor Biopharma, Inc.
Sources: the firm's website · SEC Form D filings.
Colleagues at SR One Capital Management
Alicia Hasson
Executive Assistant at SR One Capital Management
Amit Mehta
Venture Partner - US Investments at SR One Capital Management
Amit Shah
Principal at SR One Capital Management
Ann Ng
Finance Director at SR One Capital Management
Brian Gallagher
Partner at SR One Capital Management
Briana Wilson
Senior Administrative Assistant at SR One Capital Management
Catalina Kazi
Legal & Compliance Counsel at SR One Capital Management
Chris Chai
Operating Partner - Portfolio Capital Raising at SR One Capital Management
Frequently asked questions
- Who is Matthew R. Patterson?
- Matthew R. Patterson is a Venture Partner at SR One Capital Management with over 30 years in the research, development, and commercialization of therapeutics. He co-founded Audentes Therapeutics in 2012 and served as its CEO until its 2020 acquisition by Astellas Pharma, and previously worked at Genzyme, BioMarin Pharmaceutical, Amicus Therapeutics, and Iris Medicine, as well as serving as an Entrepreneur-In-Residence at OrbiMed. He holds a Bachelor's degree in Biochemistry from Bowdoin College.
- Where does Matthew R. Patterson work?
- Matthew R. Patterson is Founder of Audentes Therapeutics and Venture Partner at SR One Capital Management and Chairman of the Board of Directors at Rezo Therapeutics and Board director at Addition Therapeutics.
- What does Matthew R. Patterson invest in?
- Matthew R. Patterson invests in Biotech.
- What companies did Matthew R. Patterson found?
- Matthew R. Patterson founded Audentes Therapeutics.
- What boards does Matthew R. Patterson sit on?
- Matthew R. Patterson holds tracked board seats at Addition Therapeutics, Addition Therapeutics, Remix Therapeutics, Inc., Vor Biopharma, Inc..
- Where did Matthew R. Patterson go to school?
- Matthew R. Patterson studied at Bowdoin College (BA, Biochemistry).
Founder mafias
Bowdoin College mafia25
Also came through, then founded or led a company.
Reed HastingsBAFounded InterPositiveTed PowerFounded Versa +1Jack MorrisonFounded Agency Tool Company +1Whit SchraderBAFounded Pearescope +1Andrew PalmerBAFounded TamrCali TranABFounded Simpli-fi
+ 18 more
OrbiMed mafia10
Also came through, then founded or led a company.
Peter ThompsonGeneral PartnerFounded Cleave Biosciences +4Peter Thompson, M.D.Venture PartnerFounded Cleave Biosciences +4Iain DukesVenture PartnerFounded Viriom +1Sheila Gujrathi, MDVenture AdvisorFounded Prana Therapies +1Tadd WesselPartnerFounded PetrichorSteven YeciesVenture PartnerFounded Javelin Oncology
+ 3 more
Audentes Therapeutics mafia5
Also came through, then founded or led a company.
Remix Therapeutics mafia3
Also came through, then founded or led a company.
Vor Biopharma mafia3
Also came through, then founded or led a company.
Same school
Also attended Bowdoin College108
Reed HastingsCo-founder of NetflixHolly MaloneyInvestment Team at General CatalystKen ChenaultInvestment Team at General CatalystKevin MunnellyInvestor at Third Rock VenturesEmily PawlakVice President at Volition CapitalJohn HarthorneFounder & Managing Director at Two Lanterns Venture Partners
+ 102 more
Shared employers
Also worked at Homology Medicines, Inc.5
Also worked at Audentes Therapeutics19
Takashi FutamiPartner at AN Venture PartnersKush M ParmarManaging Partner at 5AM VenturesSatoshi KonagaiInvestment Lead at Astellas Venture Management LLCTadayoshi HirataInvestment Lead at Astellas Venture Management LLCShinichi MiyakeInvestment Lead at Astellas Venture Management LLCYusuke WadaSenior Associate at Saisei Ventures
+ 13 more
